MAP2K7 and central nervous system cancer: Work conducted by Cheng and Liu led to the finding that MUC15 activates the Raf/MEK/ERK signaling pathway, and specific ERK inhibitors reversed MUC-15’s enhanced proliferation and invasion of glioma cells, which indicates that MUC15 may have a significant role in glioma tumorigenesis [60].